Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Focus on irritable bowel syndrome.

Scalera A, Loguercio C.

Eur Rev Med Pharmacol Sci. 2012 Sep;16(9):1155-71. Review.

2.

New insights into the pathophysiology of irritable bowel syndrome: implications for future treatments.

Crowell MD, Harris L, Jones MP, Chang L.

Curr Gastroenterol Rep. 2005 Aug;7(4):272-9. Review.

PMID:
16042910
3.

Pathogenic factors involved in the development of irritable bowel syndrome: focus on a microbial role.

Bolino CM, Bercik P.

Infect Dis Clin North Am. 2010 Dec;24(4):961-75, ix. doi: 10.1016/j.idc.2010.07.005. Review.

PMID:
20937460
4.

Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last?

Bixquert Jiménez M.

Rev Esp Enferm Dig. 2009 Aug;101(8):553-64. Review.

5.

[Alterations of intestinal epithelial barrier and flora in the irritable bowel syndrome].

Piche T.

Gastroenterol Clin Biol. 2009 Feb;33 Suppl 1:S40-7. doi: 10.1016/S0399-8320(09)71524-6. French.

6.

New insights into the pathogenesis and pathophysiology of irritable bowel syndrome.

Ohman L, Simrén M.

Dig Liver Dis. 2007 Mar;39(3):201-15. Epub 2007 Jan 30. Review.

PMID:
17267314
7.

The pathophysiology of irritable bowel syndrome.

Schwetz I, Bradesi S, Mayer EA.

Minerva Med. 2004 Oct;95(5):419-26. Review.

PMID:
15467517
8.

The putative role of the intestinal microbiota in the irritable bowel syndrome.

Collins SM, Denou E, Verdu EF, Bercik P.

Dig Liver Dis. 2009 Dec;41(12):850-3. doi: 10.1016/j.dld.2009.07.023. Epub 2009 Sep 8. Review.

PMID:
19740713
9.

Traditional thoughts on the pathophysiology of irritable bowel syndrome.

Hasler WL.

Gastroenterol Clin North Am. 2011 Mar;40(1):21-43. doi: 10.1016/j.gtc.2010.12.004. Review.

PMID:
21333899
10.

Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome.

Gershon MD.

J Clin Gastroenterol. 2005 May-Jun;39(5 Suppl 3):S184-93. Review.

PMID:
15798484
11.

Irritable bowel syndrome: is the colonic mucosa to blame?

Hoffman JM.

Neurogastroenterol Motil. 2012 Dec;24(12):1051-3. doi: 10.1111/nmo.12039.

12.

The brain-gut axis in irritable bowel syndrome--clinical aspects.

Mach T.

Med Sci Monit. 2004 Jun;10(6):RA125-31. Epub 2004 Jun 1. Review.

PMID:
15173682
13.

Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome.

Ringel Y, Maharshak N.

Am J Physiol Gastrointest Liver Physiol. 2013 Oct 15;305(8):G529-41. doi: 10.1152/ajpgi.00207.2012. Epub 2013 Jul 25. Review.

14.

Update on irritable bowel syndrome and gender differences.

Heitkemper MM, Jarrett ME.

Nutr Clin Pract. 2008 Jun-Jul;23(3):275-83. doi: 10.1177/0884533608318672. Review.

PMID:
18595860
15.

Neuroimmune mechanisms in functional bowel disorders.

Wouters MM, Boeckxstaens GE.

Neth J Med. 2011 Feb;69(2):55-61. Review.

16.

Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome.

Matricon J, Meleine M, Gelot A, Piche T, Dapoigny M, Muller E, Ardid D.

Aliment Pharmacol Ther. 2012 Dec;36(11-12):1009-31. doi: 10.1111/apt.12080. Epub 2012 Oct 15. Review.

17.

[Irritable bowel syndrome: from the gut to the brain-gut].

Ducrotté P.

Gastroenterol Clin Biol. 2009 Aug-Sep;33(8-9):703-12. doi: 10.1016/j.gcb.2009.07.006. Epub 2009 Aug 13. French.

18.

Enteric P2X receptors as potential targets for drug treatment of the irritable bowel syndrome.

Galligan JJ.

Br J Pharmacol. 2004 Apr;141(8):1294-302. Epub 2004 Mar 29. Review.

19.

Probiotic agents in the treatment of irritable bowel syndrome.

Guslandi M.

J Int Med Res. 2007 Sep-Oct;35(5):583-9. Review.

PMID:
17900396
20.

Neuro-immune interactions in inflammatory bowel disease and irritable bowel syndrome: future therapeutic targets.

Kraneveld AD, Rijnierse A, Nijkamp FP, Garssen J.

Eur J Pharmacol. 2008 May 13;585(2-3):361-74. doi: 10.1016/j.ejphar.2008.02.095. Epub 2008 Mar 18. Review.

PMID:
18417115
Items per page

Supplemental Content

Write to the Help Desk